Maprotiline Hydrochloride Oral Tablet 25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Maprotiline Hydrochloride: Oral tablet (25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_926.JPG
Maprotiline 25mg Tab
Mylan Pharmaceuticals Inc.
Pill Identification: 60  |  M

What is this Medicine?

MAPROTILINE (ma PROE ti leen) is used to treat depression. This medicine also helps to relieve anxiety associated with depression.

CVS Pharmacy Patient Statistics for Maprotiline Hydrochloride: Oral tablet(25mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Maprotiline Hydrochloride 25mg Tablet

NDC: 003780060
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Depression

Sometimes used for but not FDA approved for the following conditions:
Enuresis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Maprotiline Hydrochloride 25mg Tablet
Drug Image file DrugItem_926.JPG
Mylan Pharmaceuticals Inc.
Pill Identification: 60  |  M
Shape: round
Color: white

Reported Side Effects for Maprotiline Hydrochloride 25mg Tablet

Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Gynecomastia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Galactorrhea Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Dysarthria Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Increase In Breast Size Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Incoordination Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Restlessness Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Memory Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Tongue Discoloration Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Restlessness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nightmares Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Increased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Increased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stuffy Nose Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Mania Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Bowel Obstruction Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Retaining Urine Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Convulsions Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
4.0%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
16.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
22.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Maprotiline Hydrochloride 25mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Maprotiline Hydrochloride 25mg Tablet(Maprotiline Hydrochloride)
Alcohol and Maprotiline Hydrochloride(Maprotiline Hydrochloride)
In general, it is recommended that you avoid Alcoholic drinks while you are taking Antidepressants like Maprotiline. Alcohol can affect the mood and interfere with the drug treatment, and may increase the risk of side effects. Decreased alertness, drowsiness, falls, or other side effects may occur. Do not drive or operate machinery if you are drinking Alcohol-containing beverages.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Maprotiline Hydrochloride

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5